Page Content
Course Description
With 2 presentations 'Interpreting IGRA Results: Advanced Insights for Civil Surgeons' & 'IGRA Considerations for the Civil Surgeon,' this webinar focuses on enhancing civil surgeons' and supporting healthcare professionals’ understanding of interpreting Interferon-Gamma Release Assay (IGRA) results in TB screening. As a follow-up to our introductory session on IGRA testing, this session dives deeper into the nuances of interpreting results, particularly in clinical scenarios that civil surgeons frequently encounter.
Target Audience
This series is targeted to allied health professionals, nurses, nurse practitioners, physicians, physician assistants, residents/fellows, and civil surgeons as well as advanced practice providers, nurses, and allied health staff who help support civil surgeons and status adjusters.
Learning Objectives
- Summarize the epidemiology of tuberculosis in the US
- Identify the rationale for recommending LTBI treatment
- Interpret IGRA
- Recognize the limitations and variability
- Recognize the role of Civil Surgeons in LTBI management
- Recognize steps to facilitate treatment as a Civil Surgeon